503 related articles for article (PubMed ID: 29072258)
1. A metabolic mechanism analysis of Fuzheng-Huayu formula for improving liver cirrhosis with traditional Chinese medicine syndromes.
Song YN; Chen J; Cai FF; Lu YY; Chen QL; Zhang YY; Liu P; Su SB
Acta Pharmacol Sin; 2018 Jun; 39(6):942-951. PubMed ID: 29072258
[TBL] [Abstract][Full Text] [Related]
2. Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula.
Li H
J Ethnopharmacol; 2020 Apr; 251():112442. PubMed ID: 31891799
[TBL] [Abstract][Full Text] [Related]
3. Broad range metabolomics coupled with network analysis for explaining possible mechanisms of Er-Zhi-Wan in treating liver-kidney Yin deficiency syndrome of Traditional Chinese medicine.
Zhai Y; Xu J; Feng L; Liu Q; Yao W; Li H; Cao Y; Cheng F; Bao B; Zhang L
J Ethnopharmacol; 2019 Apr; 234():57-66. PubMed ID: 30690072
[TBL] [Abstract][Full Text] [Related]
4. Fuzheng Huayu capsule as an adjuvant treatment for HBV-related cirrhosis: A systematic review and meta-analysis.
Wang T; Zhou X; Liu H; Wang J; Zhang P; Zhu Y; Li K; Wei S; Li H; Wang L; Wang R; Zhao Y
Phytother Res; 2018 May; 32(5):757-768. PubMed ID: 29235181
[TBL] [Abstract][Full Text] [Related]
5. Syndrome of liver depression and spleen deficiency is a primary TCM syndrome of response to entecavir + FuZheng HuaYu in patients with HBV-related liver fibrosis.
Dai YK; Fan HN; Zhao ZM; Shen L; Liu CH
Heliyon; 2023 Nov; 9(11):e22216. PubMed ID: 38045133
[TBL] [Abstract][Full Text] [Related]
6. Safety and therapeutic effects of anti-fibrotic Traditional Chinese Medicine Fuzheng Huayu on persistent advanced stage fibrosis following 2 years entecavir treatment: Study protocol for a single arm clinical objective performance criteria trial.
Chen Y; Zhao Z; Fan H; Li Z; He Y; Liu C
Contemp Clin Trials Commun; 2020 Sep; 19():100601. PubMed ID: 32642592
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy of fuzheng-huayu tablet based traditional chinese medicine syndrome differentiation on hepatitis-B-caused cirrhosis: a multicenter double-blind randomized controlled trail.
Song YN; Sun JJ; Lu YY; Xu LM; Gao YQ; Zhang W; Wang XS; Xue DY; Zheng QS; Su SB
Evid Based Complement Alternat Med; 2013; 2013():709305. PubMed ID: 23533516
[TBL] [Abstract][Full Text] [Related]
8. Plasma metabolic profiling on postoperative colorectal cancer patients with different traditional Chinese medicine syndromes.
Hu XQ; Wei B; Song YN; Ji Q; Li Q; Luo YQ; Wang WH; Su SB
Complement Ther Med; 2018 Feb; 36():14-19. PubMed ID: 29458921
[TBL] [Abstract][Full Text] [Related]
9. Progress in clinical and basic research of fuzheng Huayu formula for the treatment of liver fibrosis.
Zhou X; Fu Y; Chen J; Liu P
J Ethnopharmacol; 2024 Jun; 327():118018. PubMed ID: 38453100
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional Profiling and miRNA-Target Network Analysis Identify Potential Biomarkers for Efficacy Evaluation of Fuzheng-Huayu Formula-Treated Hepatitis B Caused Liver Cirrhosis.
Chen Q; Wu F; Wang M; Dong S; Liu Y; Lu Y; Song Y; Zhou Q; Liu P; Luo Y; Su S
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27271613
[TBL] [Abstract][Full Text] [Related]
11. The effect and mechanisms of Fuzheng Huayu formula against chronic liver diseases.
Chen J; Hu Y; Chen L; Liu W; Mu Y; Liu P
Biomed Pharmacother; 2019 Jun; 114():108846. PubMed ID: 30965233
[TBL] [Abstract][Full Text] [Related]
12. Metabolic mechanisms of Fuzheng-Huayu formula against liver fibrosis in rats.
Hu XQ; Song YN; Wu R; Cai FF; Zhang Y; Peng JH; Hu YY; Su SB
J Ethnopharmacol; 2019 Jun; 238():111888. PubMed ID: 31004725
[TBL] [Abstract][Full Text] [Related]
13. Chinese herbal formula Fuzheng Huayu alleviates CCl
Dong S; Cai FF; Chen QL; Song YN; Sun Y; Wei B; Li XY; Hu YY; Liu P; Su SB
Acta Pharmacol Sin; 2018 Jun; 39(6):930-941. PubMed ID: 29094729
[TBL] [Abstract][Full Text] [Related]
14. Serum metabolic profiling of traditional Chinese medicine syndromes in patients with diarrhea-predominant irritable bowel syndrome.
Tang SQ; Wang YL; Xie ZY; Zhang Y; Guo Y; Gao KL; Mao TY; Xie CE; Li JX; Gao XY
J Integr Med; 2021 May; 19(3):274-281. PubMed ID: 33775600
[TBL] [Abstract][Full Text] [Related]
15. Fuzheng Huayu inhibits carbon tetrachloride-induced liver fibrosis in mice through activating hepatic NK cells.
Cheng Q; Li N; Chen M; Zheng J; Qian Z; Wang X; Huang C; Li Q; Lin Q; Shi G
J Ethnopharmacol; 2013 Jan; 145(1):175-81. PubMed ID: 23127651
[TBL] [Abstract][Full Text] [Related]
16. MiRNA-target network analysis identifies potential biomarkers for Traditional Chinese Medicine (TCM) syndrome development evaluation in hepatitis B caused liver cirrhosis.
Liu Y; Wang M; Luo Y; Chen J; Lu Y; Shi Y; Tang C; Zhou Q; Zhang H; Hu Y; Su S; Chen Q
Sci Rep; 2017 Sep; 7(1):11054. PubMed ID: 28887510
[TBL] [Abstract][Full Text] [Related]
17. Fuzheng Huayu recipe alleviates hepatic fibrosis via inhibiting TNF-α induced hepatocyte apoptosis.
Tao YY; Yan XC; Zhou T; Shen L; Liu ZL; Liu CH
BMC Complement Altern Med; 2014 Nov; 14():449. PubMed ID: 25407538
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic study of five components of Fuzheng Huayu tablets in healthy human plasma.
Zhang H; Hu Y; Liu X; Li R; Pan Y; Liu C; Yang T
Biomed Chromatogr; 2024 Feb; 38(2):e5782. PubMed ID: 38016814
[TBL] [Abstract][Full Text] [Related]
19. [Multicenter clinical study about the action of Fuzheng Huayu Capsule against liver fibrosis with chronic hepatitis B].
Liu P; Hu YY; Liu C; Xu LM; Liu CH; Sun KW; Hu DC; Yin YK; Zhou XQ; Wan MB; Cai X; Zhang ZQ; Ye J; Tang BZ; He J
Zhong Xi Yi Jie He Xue Bao; 2003 Jul; 1(2):89-98, 102. PubMed ID: 15339577
[TBL] [Abstract][Full Text] [Related]
20. [Clinical study of yiqi huoxue recipe in the treatment of liver fibrosis of chronic viral hepatitis].
Cui LY; Zhang XX; Cui P; Li WC; Zhang YG; Wang RQ; Zhao SX; Ren WG; Kong LL; Han F; Yuan XW; Liu LD; Zhang Y; Zhang QS; Kong L; Nan YM
Zhonghua Gan Zang Bing Za Zhi; 2020 May; 28(5):403-409. PubMed ID: 32536056
[No Abstract] [Full Text] [Related]
[Next] [New Search]
